SequelSEC

Profound Medical Corp. PROF

Surgical & Medical Instruments & Apparatus · CIK 0001628808 · Fiscal year ends 1231

Revenue
$19.09M
Fiscal year ended 2026-06-30
Operating income
-$35.37M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$152.24MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$4.19Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue9.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio12.52x95th
Long-term debt / equity0.07x13th
Revenue YoY growth50.7%84th
R&D / revenue127.9%82th
SBC / revenue34.1%81th
FCF margin-238.4%20th
Net margin-264.4%20th
Operating margin-256.3%20th
CapEx / revenue1.1%27th
Gross margin70.8%71th

Profound Medical Corp. (PROF) reported revenue of $19.09M and net income of -$32.74M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Profound Medical Corp.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Profound Medical Corp. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$19.09M
Cost of revenue$5.38M
Gross profit$13.70M
Operating income-$35.37M
Net income-$32.74M
Research & development$20.61M
Weighted-average diluted sharesUnavailable
Pretax income-$32.52M
Income tax expense$227.00K
Diluted EPSUnavailable
Selling, general & administrative$28.46M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Profound Medical Corp. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$38.27M
Total assets$62.38M
Current assets$58.86M
Total liabilities$12.58M
Current liabilities$9.11M
Total equity incl. NCI$49.81M
Temporary (mezzanine) equityUnavailable
Inventory$10.46M
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debt$4.51M
Accounts payable$955.00K

Cash flow

Profound Medical Corp. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$36.10M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensation$4.97M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Profound Medical Corp. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin71.8%
Operating margin-185.3%
FCF marginUnavailable
SBC / revenue26.1%
Current ratio6.46x
Revenue YoY growth61.2%
Net margin-171.6%
R&D / revenue108.0%
CapEx / revenueUnavailable
Long-term debt / equity0.09x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PROF in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-05View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.